Table 5 Cost-effectiveness results
| Â | Patiromer | SoC | Incremental |
|---|---|---|---|
Discounted results | |||
 Total costs (£) | £116,675 | £113,701 | £2973 |
 Treatment | £1283 | £0 | £1283 |
 HK | £1091 | £1287 | -£196 |
 CKD | £27,535 | £26,628 | £907 |
 RRT | £56,877 | £56,155 | £721 |
 MACE | £9227 | £9280 | -£53 |
 Hospitalisation | £18,684 | £18,226 | £458 |
 RAASi drug usage | £153 | £130 | £23 |
 RAASi titration | £1824 | £1995 | -£170 |
 Total life years | 8.935 | 8.670 | 0.264 |
 Total QALYs | 6.356 | 6.156 | 0.201 |
 ICER (£/QALY) | - | - | £14,816 |
Undiscounted results | |||
 Total costs | £168,834 | £164,306 | £4528 |
 Total life years | 11.685 | 11.321 | 0.364 |
 Total QALYs | 8.176 | 7.904 | 0.272 |
 ICER (£/QALY) | - | - | £16,672 |